Carlos Hader

429 total citations
7 papers, 299 citations indexed

About

Carlos Hader is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Carlos Hader has authored 7 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Surgery. Recurrent topics in Carlos Hader's work include Glycosylation and Glycoproteins Research (2 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Carlos Hader is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Carlos Hader collaborates with scholars based in United States, France and Austria. Carlos Hader's co-authors include Bashar Dabbas, Brian Kwok, Keming Lin, Yin Xu, Jeff Hall, Prashanti Reddy, Christine Vaupel, John S. Witte, Shareef Nahas and Rafael Bejar and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and American Journal of Physiology-Renal Physiology.

In The Last Decade

Carlos Hader

7 papers receiving 295 citations

Peers

Carlos Hader

HEMAT

GENET

MB

ONCOL

CR

Xiu Yan Xie United States

Albert Pérez-Ladaga Spain

Liwei Fang China

Giulia Marzocchi Italy

Tetsuichi Yoshizato Japan

Diego Quinones Raffo United States

Krishnan Allampallam United States

Alexander J. Silver United States

Yingwan Luo China

Xiu Yan Xie United States

Carlos Hader

189 ×0.9

HEMAT

105 ×0.9

GENET

56 ×0.8

MB

59 ×1.1

ONCOL

23 ×0.5

CR

Citations per year, relative to Carlos Hader Carlos Hader (= 1×) peers Xiu Yan Xie

Countries citing papers authored by Carlos Hader

Since Specialization

Citations

This map shows the geographic impact of Carlos Hader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Hader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Hader more than expected).

Fields of papers citing papers by Carlos Hader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Hader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Hader. The network helps show where Carlos Hader may publish in the future.

Co-authorship network of co-authors of Carlos Hader

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Hader. A scholar is included among the top collaborators of Carlos Hader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Hader. Carlos Hader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Avet‐Loiseau, Hervé, et al.. (2023). t(11;14) status is stable between diagnosis and relapse, and concordant between detection methodologies based on fluorescence <i>in situ</i> hybridization and next-generation sequencing in patients with multiple myeloma. Haematologica. 109(6). 1874–1881. 2 indexed citations

2.

Ross, Jeremy A., et al.. (2022). Genomic Landscape of t(11;14) in Multiple Myeloma. Blood. 140(Supplement 1). 10092–10093. 2 indexed citations

3.

Rojo, Federico, Marcelo Corassa, Dimitriοs Mavroudis, et al.. (2020). International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 147. 237–243. 42 indexed citations

4.

Kwok, Brian, Jeff Hall, John S. Witte, et al.. (2015). MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 126(21). 2355–2361. 213 indexed citations

5.

Hall, Jeff, Bashar Dabbas, Christine Vaupel, et al.. (2014). Somatic Mutations Indicative of Clonal Hematopoiesis Are Present in a Large Fraction of Cytopenic Patients Who Lack Diagnostic Evidence of MDS. Blood. 124(21). 3272–3272. 7 indexed citations

6.

Hader, Carlos, et al.. (2013). Met Activation Is Required for Early Cytoprotection after Ischemic Kidney Injury. Journal of the American Society of Nephrology. 25(2). 329–337. 15 indexed citations

7.

Hader, Carlos, Sandra Tremblay, Nicolas Solban, et al.. (2005). HCaRG increases renal cell migration by a TGF-α autocrine loop mechanism. American Journal of Physiology-Renal Physiology. 289(6). F1273–F1280. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact